Hudson Valley Investment Advisors’s Ariad Pharmaceuticals Inc ARIA Stock Holding History

Hudson Valley Investment Advisors’s Portfolio ARIA Stock Details ARIA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-20,000	Closed	-$234K	–	154
2016 Q4	$234K	Hold	20,000	–	–	0.07%	137
2016 Q3	$274K	Hold	20,000	–	–	0.09%	129
2016 Q2	$148K	Hold	20,000	–	–	0.05%	144
2016 Q1	$128K	Hold	20,000	–	–	0.04%	138
2015 Q4	$125K	Hold	20,000	–	–	0.04%	142
2015 Q3	$117K	Hold	20,000	–	–	0.04%	146
2015 Q2	$165K	Buy	+20,000	New	+$177K	0.05%	139

Other funds holding ARIA

FPF

FNY Partners Fund New York $185M AUM 32.59% 1-Year Est. Return

Hudson Valley Investment Advisors's ARIA Position: Q1 2017 in Review

Hudson Valley Investment Advisors sold out of Ariad Pharmaceuticals Inc (ARIA) in Q1 2017, closing a stake of 20,000 shares — an estimated $234K sold.

Hudson Valley Investment Advisors first reported a position in ARIA in Q2 2015 and held it in 7 quarters. The position peaked at $274K in Q3 2016. 1 fund tracked by Wall St. Rank holds ARIA as of Q1 2017.

Hudson Valley Investment Advisors reported no remaining Ariad Pharmaceuticals Inc position as of Q1 2017 after selling out during the quarter.
Hudson Valley Investment Advisors sold 20,000 Ariad Pharmaceuticals Inc shares in Q1 2017, an estimated $234K.
Hudson Valley Investment Advisors first reported a position in Ariad Pharmaceuticals Inc in Q2 2015 and held it in 7 quarters.
Hudson Valley Investment Advisors's Ariad Pharmaceuticals Inc position peaked at $274K in Q3 2016.
1 fund tracked by Wall St. Rank held Ariad Pharmaceuticals Inc as of Q1 2017.

Based on Hudson Valley Investment Advisors's 13F filing for Q1 2017, filed 21 Apr 2017.